Implanet has announced successful results of the first surgical procedures using the Jazz Lock. Jazz Lock, which has both CE marking and 510K clearance, has been used in hospitals in France, Italy and the United States. The company indicates that the positive results emanating from over 25 cases mean that they are on track for an international launch of Jazz Lock by the end of the year.
Implanet: Success With Jazz Lock
2 min read Premium comments
Secondary
As indicated in the September 14, 2016 news release, “The first component of an innovative range of band products designed for degenerative spine disorder surgery, Jazz Lock broadens the Jazz technological platform, allowing Implanet to expand its activity in a spine market estimated to be worth over $200 million worldwide. Implanet offers surgeons a new implant with an optimized and reproducible surgical technique. Based on the polyester band platform, Jazz Lock simplifies the surgical procedure by replacing the locking screw and connecting rod with an innovative locking system.”
Dr. Vincent Cunin, Deputy Chief of Service in the Spine Surgery department at Hospices Civils de Lyon, said, “As a spine surgeon, I have been using band implants for the last four years to correct spine deformities, with excellent post-operative clinical results. Jazz Lock’s arrival as part of the Implanet band range is a major breakthrough. This new implant’s ease of use during the first surgical procedures in Lyon, as well as the very encouraging initial post-operative clinical results, validate our choice. We will now follow these patients to confirm the long term results. In my opinion, Jazz Lock will quickly become an indispensable spine implant to surgeons across the globe.”
Asked what makes this implant particularly easy to use, Implanet CEO Ludovic Lastennet told OTW, “Jazz Lock broadens the Jazz technological platform, allowing Implanet to expand its activity in the spine market. Implanet offers surgeons a new implant with an optimized and reproducible surgical technique. Based on the polyester band platform, Jazz Lock simplifies the surgical procedure by replacing the locking screw and connecting rod with an innovative locking system.”
He added, “Following the limited release period, we are going to launch Jazz Lock and further expands the breadth of our product offering. The official Marketing launch is scheduled for upcoming major spine congresses: Eurospine in Berlin in early October and NASS in Boston (USA) in late October.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.